Please check your internet connection and try again.
# Hyoscine butylbromide (Buscopan)
## Overview
Hyoscine butylbromide is an antimuscarinic agent that acts peripherally to relax smooth muscle. It is primarily used for its antispasmodic effects on the gastrointestinal and genitourinary tracts. It is a quaternary ammonium compound, which limits its penetration into the central nervous system, reducing central anticholinergic side effects.
## Primary Indications
* Symptomatic relief of abdominal cramping and pain associated with irritable bowel syndrome (IBS).
* Relief of spasms of the biliary and urinary tracts.
* Adjunct in diagnostic procedures requiring inhibition of GI motility.
## Adult Dosing
* **Oral:** 20 mg four times daily.
* **Injectable (IM/IV):** 20 mg every 4-6 hours as needed. Maximum daily dose of 100 mg.
## Pediatric Dosing
* **Oral:**
* Children 6-12 years: 10 mg three times daily.
* Children > 12 years: 20 mg three times daily.
* **Injectable (IM/IV):** Data is limited. The safety and efficacy have not been established in pediatric patients. Use with caution and if indicated, consider very low doses pending further data.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment due to its peripheral action and limited metabolism. However, caution should be exercised in elderly patients who may be more susceptible to anticholinergic effects.
## Contraindications
* Hypersensitivity to hyoscine butylbromide or any component of the formulation.
* Narrow-angle glaucoma.
* Myasthenia gravis.
* Tachyarrhythmias.
* Paralytic ileus or obstruction of the gastrointestinal tract.
* Megacolon.
* Prostatic hypertrophy with urinary retention.
* Cystic fibrosis patients (increased risk of adverse events).
## Adverse Effects
* **Common:** Dry mouth, blurred vision, constipation, urinary retention, tachycardia.
* **Less Common:** Skin rash, urticaria, dyshidrosis, hypotension, hypertension, dizziness, drowsiness, breathlessness.
* **Rare:** Anaphylactic shock, anaphylactic reactions.
## Key Drug Interactions
* **Other Anticholinergic Agents:** Additive effects, increasing the risk of anticholinergic side effects (e.g., tricyclic antidepressants, antihistamines, antiparkinsonian drugs).
* **Dopamine Antagonists (e.g., Metoclopramide):** May reduce the efficacy of both agents.
* **Beta-agonists:** May antagonize the effect of beta-agonists on smooth muscle.
## Monitoring
* Monitor for signs and symptoms of anticholinergic side effects (dry mouth, blurred vision, constipation, urinary retention, tachycardia).
* Monitor for hypersensitivity reactions, especially following parenteral administration.
* In patients with cardiac conditions, monitor heart rate and rhythm.
## Clinical Pearls
* Hyoscine butylbromide is a peripheral anticholinergic and is generally preferred over centrally acting agents for GI and GU spasms due to a lower incidence of CNS side effects.
* Can be used for pre-procedural bowel preparation or to relieve spasms during endoscopic procedures.
* Patient education regarding potential anticholinergic side effects is important.
***
*Disclaimer: This information is intended for healthcare professionals. Please consult current prescribing information and relevant clinical guidelines for definitive guidance. Dosing and indications may vary by local protocol and regulatory approval. Always use clinical judgment.*
